Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01887470 · ClinicalTrials.gov registry record · Phase 2
2 Regimens of Lactulose for Colonoscopy Preparation in Adults
A Phase 2 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT01887470 is a Phase 2 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 55 participants.
The verdict
NCT01887470, a Phase 2 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the efficacy of 2 regimens of lactulose as a preparation for colonoscopy.
Interventions
- DRUG Full dose preparation
- DRUG Split dose preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2013-07 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01887470
The ClinicalTrials.gov registry entry for NCT01887470 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Full dose preparation is the first listed.
NCT01887470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01887470 about?
NCT01887470 is a clinical study titled "2 Regimens of Lactulose for Colonoscopy Preparation in Adults". The purpose of the study is to determine the efficacy of 2 regimens of lactulose as a preparation for colonoscopy.
What is the current status of trial NCT01887470?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2013-07. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01887470?
The interventions under investigation include: Full dose preparation (DRUG), Split dose preparation (DRUG).
Who is sponsoring clinical trial NCT01887470?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.